Infectious Diseases
Adherence to CDSIC regulatory standards.
Building epidemiological models to simulate the spread of COVID-19 at various geographical and social-economic settings
Pharma companies are coming under increasing pressure to deliver complex solutions of vaccine and anti-infective drug development faster. Since 2015, Intego Clinical has delivered biometrics services in the field of infectious disease. Regardless of project scope or drug development phase, our team of experts goes above and beyond for every client.
Intego Clinical’s infectious disease strengths:
- Over 5 years’ experience supporting infectious disease trials, in particular influenza
- Adherence to CDSIC regulatory standards
- Experience working on trials with vulnerable and pediatric patient populations
- We can handle a large volume of complex parameters and sophisticated trials endpoints
- Excellent knowledge of genetics and virology to bring to bear on infectious disease projects
- Building epidemiological models to simulate the spread of COVID-19 at various geographical and social-economic settings
Every year, between 9 and 45 million people around the world suffer from influenza. The World Health Organisation identifies infectious disease as one of the leading causes of death. Given the rise of antibiotic resistance and rapid evolution of new viral strains, developing new cures for infectious diseases requires resilience and quick-thinking.
The COVID-19 pandemic has highlighted the importance of infectious disease clinical research, and pharma companies are coming under increasing pressure to deliver crucial clinical results faster, and report on more complex clinical endpoints. When choosing a biometrics CRO to analyze their clinical data, pharma and biotech companies need a resourceful, agile partner to see their trials through to completion.
Understanding the spread of COVID-19 in the US
Real-world data can be essential for our understanding of clinical data, especially with the emergence of phenomena such as the COVID-19 outbreak. Leveraging topology and machine learning for time series, we analyzed how the spread of pandemic has advanced across the United States.
We identified the underlying geometry of the datasets and discovered a set of unrelated features that could possibly be causing the similarity in the spread of COVID-19 across 3000+ counties.
Our Infectious Disease Expertise
At Intego Clinical, our team of experienced statistical programmers, data managers and regulatory experts are here to help you meet your trial endpoints and ensure your data conforms to global regulatory standards.
Whether you need assistance with a single project, or are looking for a multi-year partnership, Intego Clinical provides customized data management and programming solutions to meet your individual needs.
